SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17692742
Source:
http://linkedlifedata.com/resource/pubmed/id/17692742
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0034787
,
umls-concept:C0051133
,
umls-concept:C0205263
,
umls-concept:C0264716
,
umls-concept:C0332206
,
umls-concept:C0680242
,
umls-concept:C1524062
,
umls-concept:C1555029
pubmed:issue
7
pubmed:dateCreated
2007-8-13
pubmed:abstractText
The objective of this study was to determine if adding spironolactone to an angiotensin II receptor blocker improves left ventricular (LV) function, mass, and volumes in chronic heart failure.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17692742-17692743
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/candesartan
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1558-3597
pubmed:author
pubmed-author:ChanAnna K YAK
,
pubmed-author:ChanWilson W MWW
,
pubmed-author:LamWynnieW
,
pubmed-author:LamYat-YinYY
,
pubmed-author:LimaM VMV
,
pubmed-author:SandersonJohn EJE
,
pubmed-author:WangMeiM
,
pubmed-author:WangTianT
,
pubmed-author:WongJohn T HJT
,
pubmed-author:WuEugene BEB
,
pubmed-author:YeungLeataL
,
pubmed-author:YipGabrielG
,
pubmed-author:YuCheuk-ManCM
,
pubmed-author:ZhangYanY
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
591-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17692742-Aged
,
pubmed-meshheading:17692742-Aldosterone Antagonists
,
pubmed-meshheading:17692742-Angiotensin II Type 1 Receptor Blockers
,
pubmed-meshheading:17692742-Benzimidazoles
,
pubmed-meshheading:17692742-Double-Blind Method
,
pubmed-meshheading:17692742-Drug Therapy, Combination
,
pubmed-meshheading:17692742-Female
,
pubmed-meshheading:17692742-Heart Failure
,
pubmed-meshheading:17692742-Humans
,
pubmed-meshheading:17692742-Male
,
pubmed-meshheading:17692742-Middle Aged
,
pubmed-meshheading:17692742-Prospective Studies
,
pubmed-meshheading:17692742-Spironolactone
,
pubmed-meshheading:17692742-Tetrazoles
,
pubmed-meshheading:17692742-Treatment Outcome
,
pubmed-meshheading:17692742-Ventricular Remodeling
pubmed:year
2007
pubmed:articleTitle
Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure.
pubmed:affiliation
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial